99 related articles for article (PubMed ID: 2289219)
1. Nifedipine retard in the treatment of hypertension. A study using ambulatory blood pressure recordings.
Hwang YS
Clin Ther; 1990; 12(6):503-12. PubMed ID: 2289219
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S
J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609
[TBL] [Abstract][Full Text] [Related]
4. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
Manyemba J
Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
[TBL] [Abstract][Full Text] [Related]
5. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537
[TBL] [Abstract][Full Text] [Related]
6. Side effects of dihydropyridine therapy: comparison of amlodipine and nifedipine retard.
Hosie J; Bremner AD; Fell PJ; James GV; Saul PA; Taylor SH
J Cardiovasc Pharmacol; 1993; 22 Suppl A():S9-12. PubMed ID: 7522287
[TBL] [Abstract][Full Text] [Related]
7. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
Harder S; Rietbrock S; Thürmann P
Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two formulations of nifedipine during 24-hour ambulatory blood pressure monitoring.
Granberry MC; Gardner SF; Schneider EF; Carter IR
Pharmacotherapy; 1996; 16(5):932-6. PubMed ID: 8888089
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients.
Ding YA; Law HW; Chou TC
J Hum Hypertens; 1994 Feb; 8(2):137-43. PubMed ID: 8207740
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
Kirby BJ; Kitchin NR
Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of the efficacy and tolerance of delayed-action nifedipine as the monotherapy or in combination with metoprolol in patients with arterial hypertension].
Isaĭkina OIu; Gorbunov VM; Andreeva GF; Dmitrieva NA; Martsevich SIu
Ter Arkh; 2003; 75(12):39-43. PubMed ID: 14959468
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
17. Slow-release metoprolol and nifedipine in essential hypertension: 24 hour noninvasive ambulatory blood pressure monitoring.
Lattuada S; Antivalle M; Rindi M; Montanari M; Alberti D; Libretti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S99-101. PubMed ID: 2455155
[TBL] [Abstract][Full Text] [Related]
18. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension.
Minami J; Numabe A; Andoh N; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
Br J Clin Pharmacol; 2004 May; 57(5):632-9. PubMed ID: 15089817
[TBL] [Abstract][Full Text] [Related]
19. Combination of nifedipine and carteolol compared to nifedipine alone in diurnal blood pressure variation and exercise blood pressure in patients with essential hypertension.
Inoue I; Matsuura H; Fujii T; Ishida T; Ozono R; Kainouchi M; Tsuchioka Y; Kajiyama G
Clin Ther; 1992; 14(1):22-9. PubMed ID: 1576623
[TBL] [Abstract][Full Text] [Related]
20. Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study.
Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Divitiis O
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):190-6. PubMed ID: 2365538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
